VACCA, ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 36.788
NA - Nord America 2.627
AS - Asia 317
AF - Africa 2
OC - Oceania 2
Totale 39.736
Nazione #
IT - Italia 36.069
US - Stati Uniti d'America 2.614
SE - Svezia 264
UA - Ucraina 245
CN - Cina 235
GB - Regno Unito 60
FI - Finlandia 58
DE - Germania 56
SG - Singapore 54
FR - Francia 18
CA - Canada 13
IN - India 8
VN - Vietnam 8
IR - Iran 7
RU - Federazione Russa 6
BE - Belgio 4
IE - Irlanda 2
NL - Olanda 2
NZ - Nuova Zelanda 2
CZ - Repubblica Ceca 1
ES - Italia 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
LU - Lussemburgo 1
MU - Mauritius 1
PL - Polonia 1
SD - Sudan 1
TR - Turchia 1
TW - Taiwan 1
Totale 39.736
Città #
Cagliari 35.310
Uta 653
Fairfield 351
Woodbridge 327
Chandler 218
Houston 185
Nyköping 185
Ann Arbor 156
Ashburn 155
Wilmington 147
Seattle 143
Jacksonville 134
Cambridge 130
Boardman 127
Dearborn 85
Nanjing 45
Santa Clara 44
Boston 34
Shanghai 29
Singapore 26
San Diego 24
Shenyang 21
Beijing 18
Redwood City 16
Hebei 15
Helsinki 15
San Mateo 15
Milan 13
Guangzhou 12
Nanchang 12
Toronto 11
Auburn Hills 10
Falls Church 10
Jiaxing 10
London 10
Norwalk 10
Dong Ket 8
Verona 8
Changsha 7
Mountain View 7
Tianjin 7
Hefei 6
Orange 6
Augusta 5
Borås 5
Duncan 5
Jinan 5
Ardabil 4
Brussels 4
Chicago 4
Renton 4
Zhengzhou 4
Cepagatti 3
Detroit 3
Hangzhou 3
Indiana 3
Kilburn 3
Kunming 3
Sassari 3
Amsterdam 2
Dublin 2
Fellbach 2
Leawood 2
Los Angeles 2
Mumbai 2
New Bedfont 2
Ningbo 2
Nürnberg 2
Oakville 2
Paris 2
Phoenix 2
Rome 2
Shaoxing 2
Taizhou 2
Tehran 2
Washington 2
Wuhan 2
Xian 2
Baghdad 1
Bologna 1
Cellatica 1
Columbus 1
Costa Mesa 1
Dalian 1
Delhi 1
Forest City 1
Foshan 1
Fremont 1
Fuzhou 1
Hamilton 1
Harbin 1
Hastings 1
Heze 1
Hounslow 1
Islington 1
Jinhua 1
Katowice 1
Leyton 1
Lissone 1
Luxembourg 1
Totale 38.876
Nome #
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study 2.478
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.248
Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests 2.040
Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time 1.830
Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study 1.689
Does subclinical atherosclerosis really exist in systemic sclerosis? Comment on the article by Turiel et al. 1.562
Genetics of seronegative spondyloarthritis, susceptibility and aetiopathogenesis: A single centre experience 1.354
The growing role of cardiac magnetic resonance imagin in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis 1.170
Vitamin D levels and potential impact in systemic sclerosis 1.035
Patient Assessments of Skin, Joint, and Nail Disease Activity in Psoriatic Arthritis Reply 1.011
Post-Streptococcal Reactive Arthritis Associated With Group G Streptococcal Pharyngitis 952
Multiple Septic Bursitis and Spontaneous Achilles Tendon Tear in Systemic Lupus Erythematosus 915
Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission 911
Prediction of Pulmonary Hypertension Related to Systemic Sclerosis by an Index Based on Simple Clinical Observations 887
Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry 884
Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis 832
HLA-B*2709 and lack of susceptibility to sacroiliitis: further support from the clinic 831
Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis: comment on the article by Mok et al 815
Expert Agreement on EULAR/EUSTAR Recommendations for the Management of Systemic Sclerosis 793
Associated Autoimmune Diseases in Systemic Sclerosis Define a Subset of Patients with Milder Disease: Results from 2 Large Cohorts of European Caucasian Patients 789
Familial chilblain and late contractural arachnodactyly: A novel association? 769
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study 767
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database 767
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study 759
A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia 757
Treatment of Systemic Sclerosis Complications: What to Use When First-Line Treatment Fails-A Consensus of Systemic Sclerosis Experts 740
Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. 738
Genetics of psoriasis and psoriatic arthritis 730
Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography. A myocardial echostress scleroderma pattern 718
Absence of epicardial coronary stenosis in patients with systemic sclerosis and severe impairment of coronary flow reserve 656
The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: A unifying hypothesis 644
Primary antiphospholipid syndrome with mesenteric venous thrombosis presenting with intestinal infarction: a case description 629
Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease 628
Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies 622
null 622
Vitamin D Deficiency and Insufficiency in 2 Independent Cohorts of Patients with Systemic Sclerosis 615
Detection of early impairment of coronary flow reserve in patients with systemic sclerosis 610
Vitamin D Deficiency in a Cohort of Patients with Systemic Scleroderma from the South of Spain Reply 569
Bleomicin induced scleroderma: report of a case with a chronic course rather than the typical acute/subacute self-limiting form 558
Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia : Implications for disease pathogensis 549
Right atrial thrombosis in systemic lupus erythematosus 471
[The role of HLA-B27 molecules in the pathogenesis of ankylosing spondylitis]. FT Il ruolo delle molecole HLA-B27 nella patogenesi della spondilite anchilosante. 396
MICA gene triplet repeat polymorphism in patients with HLA-B27 positive and negative ankylosing spondylitis from sardinia 322
Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: A pilot study 170
Totale 39.832
Categoria #
all - tutte 53.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.315 0 0 0 0 3.743 2.518 1.113 255 174 131 136 245
2020/202110.686 318 308 416 3.237 2.607 1.104 1.085 544 97 242 293 435
2021/20221.892 134 147 88 113 123 208 211 84 197 90 129 368
2022/20232.494 344 272 225 184 257 245 138 303 154 117 126 129
2023/20242.976 124 125 127 229 336 499 435 208 131 236 283 243
2024/20252.530 371 642 632 619 266 0 0 0 0 0 0 0
Totale 39.832